Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features-Reference-Cited by-同舟云学术

Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features

Published:2003-02-20 Issue:5 Volume:97 Page:1276-1284
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

van den Bent Martin J.,Looijenga Leendert H. J.,Langenberg K.,Dinjens Winand,Graveland Wilfried,Uytdewilligen Ludo,Sillevis Smitt Peter A.,Jenkins Robert B.,Kros Johan M.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference25 articles.

1. Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group.

2. Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy

3. Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas

4. Alterations of Chromosome Arms 1p and 19q as Predictors of Survival in Oligodendrogliomas, Astrocytomas, and Mixed Oligoastrocytomas

5. Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype

Cited by 171 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High Radiation Dose to the Fornix Causes Symptomatic Radiation Necrosis in Patients with Anaplastic Oligodendroglioma;Yonsei Medical Journal;2024

2. Evaluation of chromosome 1p/19q deletion by Fluorescence in Situ Hybridization (FISH) as prognostic factors in malignant glioma patients on treatment with alkylating chemotherapy;Cancer Genetics;2023-11

3. T2-FLAIR mismatch sign correlates with 11C-methionine uptake in lower-grade diffuse gliomas;Journal of Neuro-Oncology;2023-08

4. Evaluation Criteria for Chromosome Instability Detection by FISH to Predict Malignant Progression in Premalignant Glottic Laryngeal Lesions;Cancers;2022-07-03

5. Bioinformatics analysis of C3 in brain low-grade gliomas as potential therapeutic target and promoting immune cell infiltration;Medical Oncology;2022-01-11